Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 17;91(24):15608-15616.
doi: 10.1021/acs.analchem.9b03671. Epub 2019 Dec 3.

Gas-Phase Sequencing of Cyclotides: Introduction of Selective Ring Opening at Dehydroalanine via Ion/Ion Reaction

Affiliations

Gas-Phase Sequencing of Cyclotides: Introduction of Selective Ring Opening at Dehydroalanine via Ion/Ion Reaction

David J Foreman et al. Anal Chem. .

Abstract

The gas-phase linearization of cyclotides via site-selective ring opening at dehydroalanine residues and its application to cyclotide sequencing is presented. This strategy relies on the ability to incorporate dehydroalanine into macrocyclic peptide ions, which is easily accomplished through an ion/ion reaction. Triply protonated cyclotide cations are transformed into radical cations via ion/ion reaction with the sulfate radical anion. Subsequent activation of the cyclotide radical cation generates dehydroalanine at a single cysteine residue, which is easily identified by the odd-electron loss of ·SCH2CONH2. The presence of dehydroalanine in cyclotides provides a site-selective ring-opening pathway that, in turn, generates linear cyclotide analogues in the gas phase. Unlike cyclic variants, product ions derived from the linear peptides provide rich sequence information. The sequencing capability of this strategy is demonstrated with four known cyclotides found in Viola inconspicua, where, in each case, greater than 93% sequence coverage was observed. Furthermore, the utility of this method is highlighted by the partial de novo sequencing of an unknown cyclotide with much greater sequence coverage than that obtained with a conventional Glu-C digestion approach. This method is particularly well-suited for cyclotide species that are not abundant enough to characterize with traditional methods.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
General cyclotide structure showing the head-to-tail cyclic backbone and three disulfide bonds forming the cyclic cysteine knot.
Figure 2.
Figure 2.
Ion/ion reaction between triply protonated cyI4 and sulfate radical anion: (a) post ion/ion reaction spectrum, (b) beam-type CID of [M + 3H + SO4]2+•, (c) ion trap CID of [M + H]2+•, and (d) DDC-CID of the ion/ion reaction products of (a).
Figure 3.
Figure 3.
Product ion spectrum from the collisional activation of dehydroalanine containing cyI4, [M + H – 90]2+. The lightning bolt corresponds to the species CID.
Figure 4.
Figure 4.
Individual fragmentation maps of cyI4 opened at (a) Cys1, (b) Cys2, (c) Cys3, (d) Cys4, (e) Cys5, and (f) Cys6. (g) Cumulative fragmentation map from all ring openings.
Figure 5.
Figure 5.
Venn diagram showing the unique and overlapping fragment ions from activation of the cyI4 [M + H – 90]2+ ion.
Figure 6.
Figure 6.
Cumulative fragmentation maps of (a) cyO8, (b) cyI2, and (c) viba11.
Figure 7.
Figure 7.
General produce for de novo sequencing.
Figure 8.
Figure 8.
LC-MS/MS analysis of reduced and alkylated Glu-C digested [unknown + 4H]4+ using (a) targeted CID or (b) targeted EThcD as an activation method. (c). The combined fragmentation maps of (a) and (b).

Similar articles

Cited by

References

    1. Craik DJ, Daly NL, Bond T, Waine C: Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol 294, 1327–1336 (1999) - PubMed
    1. Colgrave ML, Craik DJ: Thermal, Chemical, and Enzymatic Stability of the Cyclotide Kalata B1: The Importance of the Cyclic Cystine Knot. Biochemistry. 43, 5965–5975 (2004) - PubMed
    1. Jagadish K, Camarero JA: Cyclotides, a promising molecular scaffold for peptide-based therapeutics. J. Pept. Sci 94, 611–616 (2010) - PMC - PubMed
    1. Henriques ST, Craik DJ: Cyclotides as templates in drug design. Drug Discov. Today 15, 57–64 (2010) - PubMed
    1. Poth AG, Chan LY, Craik DJ: Cyclotides as grafting frameworks for protein engineering and drug design applications. J. Pept. Sci 100, 480–491 (2013) - PubMed

Publication types